arrow
H

Hisayuki Katsuyama

japan institute for health security
H指数:23
被引数:2,825

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retrospective Longitudinal Observational Study on the Long-Term Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetic Japanese Patients

钠-葡萄糖Cotransporter-2抑制剂对日本2型糖尿病患者代谢功能障碍相关的脂肪性肝病发展的长期影响的回顾性纵向观察研究

2024-08-211
OAAI
Effects of Once-Weekly Semaglutide on Cardiovascular Risk Factors and Metabolic Dysfunction-Associated Steatotic Liver Disease in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study Based on Real-World Data

每周一次的Semaglutide对日本2型糖尿病患者心血管危险因素和代谢功能障碍相关的脂肪性肝病的影响: 基于真实世界数据的回顾性纵向研究

2024-05-025
OAAI
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial

在控制良好的2型糖尿病患者中,Empagliflozin可有效降低肝脏脂肪含量: 一项随机,双盲,4期,安慰剂对照试验

2019-09-20211
OAAI